CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis

<div><b>(</b>a) Kaplan-Meier curve analysis of CYP1B1-AS1 for the overall survival in GBM patients from TCGA datasets. (b) There is a significant correlation between CYP1B1-AS1 expression and CYP1B1 expression in GBM patients.</div>

Disease Markers

fig1

Figure 1

Figure 1: CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis 